References:

[1] Bagherani N. Comparison of pimecrolimus with clobetasol propionate in the treatment of localized vitiligo. [ J] . Dermatologic Therapy, 2015, 43( 13) :1142 -1144.
[2] Czarnowicki T, He H, Leonard A, et al. Blood endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune skin diseases[ J] . J. Allergy Clin. Immunol, 2018, 11.
[3]孙永新,宋坪.张作舟治疗白癜风经验[J] . Journal of Traditional Chinese Medicine, 2006, 47( 3) :178 -178.
[4]欧阳杰.郖国维治疗白癜风经验及相关中药研究[J].江西中医药,2009,40(9):17-18.
[5]刘晓玉,许爱娥.当代8位名老中医论治白癜风经验荟萃[J].中国中西医结合皮肤性病学杂志,2008,7(2):131-132.
[6]郭双庚.滋补肝肾为主治疗白癜风[J].中医杂志,1993,34(3):180.
[7]王辉,王莒生,王萍.中药滋补肝肾方对鼠B16黑素瘤细胞酪氨酸酶mRNA表达的调节[J].中国皮肤性病学杂志,2003,17(4):230-231.
[8]王鹰,李海东,孙仁美.补骨脂对SCF/Kit/MITF信号通路的调控作用[J].中国皮肤性病学杂志,2011,25(9):657-663.
[9]杜娟,夏佳楠,沈丽,等.菟丝子?骨碎补提取物体外对酪氨酸酶活性的影响[J].天津中医药大学学报,2013,32(1):52-54.
[10]阮高波,许爱娥.白癜风中药内服方剂的组方原则及用药分析[J].浙江中医药大学学报,2007,31(6):729-730.
[11]李永伟,许爱娥,尉晓冬,等.女贞子对黑素细胞的黑素合成?细胞增殖和c-kit基因表达的影响[J].中国中西医结合皮肤性病学杂志,2005,4(3):150-152.
[12]许小华,郝鹏飞,杨云,等.墨旱莲多糖对正常小鼠免疫功能的实验研究[J].中国实验方剂学杂志,2010,16(5):181-182.
[13]涂彩霞,刘之力,任凤,等.47种中药对酪氨酸酶活性的影响及酶动力学的研究[J].中国麻风皮肤病杂志,2006,22(6):456-458.
[14]李晓捷,尤海燕,杨晶,等.中药菟丝子水提取物促毛囊无色素黑素细胞分化的实验研究[J].中国皮肤性病学杂志,2008,22(1):4-5.
[15]雷铁池,朱文元,夏明玉,等.89味中药乙醇提取物对酪氨酸酶活性的上调作用[J].临床皮肤科杂志,1999,28(3):147-149.
[16]倪梁红,秦民坚.知母资源化学及药理研究进展[J].中国野生植物资源,2005,24(4):16-20.
[17] Chen X, Oppenheim J, Howard O M. Shikonin, a component of antiinflammatory Chinese herbal medicine, selectively blocks chemokine binding to CC chemokine receptor - 1. [ J ] . International Immunopharmacology,2001, 1( 2) :229 -236.
[18] Wu Z, Wu L, Li L, et al. p53 - mediated cell cycle arrest and apoptosis induced by shikonin via a caspase -9 -dependent mechanism in human malignant melanoma A375- S2 cells. [ J] . Journal of Pharmacological Sciences,2004, 94( 2) :166 -176.
[19] Staniforth, Vanisree, et al. “ Shikonins, Phytocompounds from Lithospermum erythrorhizon, Inhibit the Transcriptional Activation of Human Tumor Necrosis Factor α Promoter in Vivo. ” Journal of Biological Chemistry 279. 7 ( 2004) :5877.